Navigation Links
Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
Date:2/7/2008

MELVILLE, N.Y., Feb. 7 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), the nation's leading provider of comprehensive home health services, announced today that its CareCentrix(R) ancillary care benefit management unit has signed an extension of its current national homecare contract with CIGNA HealthCare, which will provide for the coordination and delivery of homecare services to CIGNA members through January 31, 2011. The extension amends a previous agreement that was set to expire January 31, 2009.

CareCentrix has been the largest national provider of homecare and related services to CIGNA HealthCare members since 1996. The extension calls for CareCentrix to continue to coordinate the provision of direct home health services, including home infusion therapy services and certain specialty medical equipment, to CIGNA HealthCare members through the CareCentrix network of nearly 4,000 credentialed provider locations. For the first nine months of 2007, the CIGNA HealthCare relationship contributed approximately 19% of total Gentiva revenues of $915.9 million.

"CIGNA HealthCare and CareCentrix have enjoyed a longstanding and mutually beneficial relationship in the delivery of homecare services to CIGNA members," said Gentiva Chairman and CEO Ron Malone. "We're pleased that CIGNA HealthCare has once again recognized CareCentrix' excellence in care coordination and customer service by agreeing to this early contract extension. We're proud of the outstanding work performed each day by the CareCentrix team in serving all of its managed care customers."

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health and related services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix(R), which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-G

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others: the Company's ability to successfully execute its growth strategy; the impact of significant indebtedness on the Company's liquidity and its ability to meet the requirements of its creditors; general economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to implementation of new business systems, or due to natural disasters or terrorist acts; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 31, 2006.

Financial and Investor Contact: John R. Potapchuk

631-501-7035

john.potapchuk@gentiva.com

Media Contact: David Fluhrer

631-501-7102, 516-589-0778

david.fluhrer@gentiva.com


'/>"/>
SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
2. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
3. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
4. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
5. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
6. Gentiva(R) Health Services Files Universal Shelf Registration Statement
7. From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance
8. Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients
9. NIH, Gates Foundation to support Riley Hospital and MoiU Program For Woman and Infant Health Researc
10. Access Is Not Enough: What It Will Take to Transform Health Care in the United States
11. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... ... 29, 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. ... patients, with or without a referral. Dr. Cotey knows that interceptive orthodontics ... experience. When patients receive early treatment, they may achieve straight teeth with less treatment ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Curio Wellness ... to announce the finalization of the company’s executive management team with prominent executives from ... operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... Philadelphia, PA (PRWEB) , ... March 29, 2017 , ... ... Moelis, W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift ... a deferred admission opportunity that will provide a pathway to a Wharton MBA for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... to 2023" report to their offering. ... The ablation device global market is ... million by 2023. Ablation is the minimally invasive ... from cancerous or diseased tissue removal, to the removal of abnormally ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
(Date:3/29/2017)... , March 29, 2017   Royal ... leader in health technology, and PathAI, a company ... collaborating with the aim to develop solutions that ... of cancer and other diseases. The partnership aims ... enabling this form of artificial intelligence to be ...
Breaking Medicine Technology: